Hydroablation Device Shows Promise for Early Prostate Cancer
A hydroablation device for benign prostatic hyperplasia showed promise as a potential treatment aid for early prostate cancer in a small Chinese study. The proportion
A hydroablation device for benign prostatic hyperplasia showed promise as a potential treatment aid for early prostate cancer in a small Chinese study. The proportion
Sen. Bill Cassidy, MD (R-La.), said he received numerous pledges from Robert F. Kennedy Jr. and the Trump administration to protect medicine and science —
Amid a political environment in which government websites are being gutted of vital health information, the American College of Obstetricians and Gynecologists (ACOG) has stepped
Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is
Studies censored by government employees will have a tough time getting published in the American Journal of Public Health (AJPH), the journal’s leadership said during
Modifying the quadruplet regimen of isatuximab, bortezomib, lenalidomide, and dexamethasone could allow older, frail patients with transplant-ineligible multiple myeloma to benefit from the therapy. The
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson’s disease, Supernus Pharmaceuticals announced on Tuesday. The
Khan is a neurologist. Imagine leaving your home on a bitter-cold morning, -10°F, scraping ice off your car, and trudging through the freezing air to
Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is
Concentrations of microplastics and nanoplastics were higher in brain tissue than they were in liver or kidney tissue in post-mortem samples. (Nature Medicine) People with